已收盤 10-31 16:00:00 美东时间
-0.020
-0.65%
ProKidney Corp. will present two posters at the American Society of Nephrology's Kidney Week 2025 in Houston, TX, on November 6-9: one on the Phase 2 REGEN-007 study results for renal autologous cell therapy in diabetes and CKD, and another on the inflammatory profile of rilparencel. The posters will be available on the company’s website post-event. ProKidney focuses on developing cellular therapies for chronic kidney disease, with its lead candi...
10-20 11:30
ProKidney ( ($PROK) ) has issued an update. ProKidney Corp. announced that on O...
10-18 05:00
As previously disclosed, on May 8, 2025, ProKidney Corp. (the "Company"), through its wholly owned subsidiary, ProKidney Acquisition Company, LLC ("Acquisition Sub"), entered into a purchase and sale agreement with
10-18 04:41
Chamath Palihapitiya is back with another SPAC. This time he's telling retail investors to stay away. Here's why.
10-02 23:32
网红股OpenDoor一夜飙升近80%!公司高管团队调整;传埃里森家族正筹备收购,华纳兄弟探索频道大涨超29%>>
09-12 14:23
ProKidney Corp., a leader in cellular therapeutics for chronic kidney disease, announced that senior management will participate in two upcoming healthcare conferences: the Citi Biopharma Back to School Conference in Boston on September 3, 2025, and the Morgan Stanley Global Healthcare Conference in New York on September 8, 2025. Both events will feature fireside chat sessions available via live webcast. Additional details, including webcast link...
08-27 11:30
Chamath Palihapitiya is back with a new SPAC. Many investors will remember past SPACs the investor was involved with and the poor performance track record.
08-19 23:53
https://www.zacks.com/stock/news/2589077/prokidney-cp-prok-upgraded-to-strong-buy-what-does-it-mean-for-the-stock
07-17 23:52
UBS analyst Eliana Merle maintains ProKidney (NASDAQ:PROK) with a Buy and raises the price target from $4 to $8.
07-15 22:23
U.S. stock futures were higher this morning, with the Nasdaq futures gaining ar...
07-15 20:40